SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-280820
Filing Date
2023-11-20
Accepted
2023-11-20 18:30:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 34399
2 GRAPHIC g721335g06f71.jpg GRAPHIC 2041
3 GRAPHIC g721335g1121011240750.jpg GRAPHIC 1656
  Complete submission text file 0001193125-23-280820.txt   40705
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)